TrialHuman molecular genetics2022

The dihydrofolate reductase 19-bp deletion modifies the beneficial effect of B-vitamin therapy in mild cognitive impairment: pooled study of two randomized placebo-controlled trials.

Yuanyuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.